COTXF (Coiled Therapeutics) Pretax Margin %: % (As of Dec. 2025)


COTXF Coiled Therapeutics PLC COTXF
21 GF Score
Price $0.15
! 4 Warning Signs
View Full Analysis

What is Coiled Therapeutics Pretax Margin %?

Coiled Therapeutics COTXF 21 Pretax Margin % is % as of Dec. 2025. GuruFocus rates COTXF with a GF Score™ of 21/100. The stock has 4 warning signs investors should review. Among 947 Biotechnology companies, Coiled Therapeutics ranks worse than 105596.52% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Coiled Therapeutics's Pre-Tax Income for the six months ended in Dec. 2025 was $-3.85 Mil. Coiled Therapeutics's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Coiled Therapeutics's pretax margin for the quarter that ended in Dec. 2025 was %.

The historical rank and industry rank for Coiled Therapeutics's Pretax Margin % or its related term are showing as below:


COTXF's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -92.22
* Ranked among companies with meaningful Pretax Margin % only.

Coiled Therapeutics  (OTCPK:COTXF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Coiled Therapeutics Pretax Margin % Related Terms

Coiled Therapeutics Pretax Margin % Historical Data

* Premium members only.

The historical data trend for Coiled Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Coiled Therapeutics Pretax Margin % Chart

Coiled Therapeutics Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Pretax Margin %
0.00 0.00 -966.80 0.00 0.00

Coiled Therapeutics Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

COTXF vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, Coiled Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coiled Therapeutics Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coiled Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Coiled Therapeutics's Pretax Margin % falls into.


COTXF
21GF Score
Coiled Therapeutics PLC COTXF
Pretax Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Coiled Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Coiled Therapeutics's Pretax Margin for the fiscal year that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-4.557/0
= %

Coiled Therapeutics's Pretax Margin for the quarter that ended in Dec. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-3.845/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
Coiled Therapeutics (COTXF) has a Pretax Margin % of % as of Dec. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Coiled Therapeutics and its competitors. According to the industry distribution chart, Coiled Therapeutics ranks #999999 out of 947 companies in the Biotechnology industry.
Is Coiled Therapeutics' Pretax Margin % too high?
Coiled Therapeutics' current Pretax Margin % is %. Based on the distribution chart, Coiled Therapeutics ranks #999999 out of 947 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Coiled Therapeutics has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Coiled Therapeutics' Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Coiled Therapeutics ranks #999999 out of 947 companies for Pretax Margin %. This places Coiled Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Coiled Therapeutics and its competitors. Coiled Therapeutics's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coiled Therapeutics stock overvalued right now?
Coiled Therapeutics (COTXF) has a current Pretax Margin % of %. The current Pretax Margin % is %. Coiled Therapeutics' overall GF Score™ is 21/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Coiled Therapeutics (COTXF), the current Pretax Margin % is % as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Coiled Therapeutics Business Description

Other Exchanges COIL:UK0AG0:Germany
Address 85 Great Portland Street, First Floor, London, GBR, W1W 7LT
Coiled Therapeutics PLC principal activity of the Company is to develop pre-clinical next generation medicines focused on hard-to-treat cancers. The Group operated in the single business segment of biotechnology.
21GF Score

Get the complete analysis for COTXF

Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.15
Price